*J Antimicrob Chemother* 2019; **74**: 3555--64

An error was present in the original published version of this article. In Table 4, in the penultimate row, the entry 'Week 12' in the RT column should have read 'none'. This has now been corrected.

###### 

Genotypic and phenotypic profiles of participants in the RAP

  No.                                          Treatment group                           Visit name   Visit type         HIV-1 RNA (copies/mL)                                   Resistance substitutions[^a^](#tblfn2){ref-type="table-fn"}   Drug susceptibility (fold change from WT)[^b^](#tblfn3){ref-type="table-fn"}                                                      
  -------------------------------------------- ----------------------------------------- ------------ ------------------ ------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------------------------ ------ ------- ------ ------- ------ ------ ------ ------
  1                                            BIC/FTC/TAF                               baseline     first              \<50                                                    M50I                                                          none                                                                             --     --      --     --      --     --     --     --
  week 12                                      last[^c^](#tblfn4){ref-type="table-fn"}   928          AF                 AF                                                      AF                                                            AF                                                                               AF     AF      AF     AF      AF     AF          
  2                                            BIC/FTC/TAF                               baseline     first              28                                                      none                                                          K70K/R, M184M/V                                                                  --     --      --     --      --     --     --     --
  week 12[^d^](#tblfn5){ref-type="table-fn"}   last[^c^](#tblfn4){ref-type="table-fn"}   2860         none               M184V                                                   0.78                                                          0.99                                                                            3.51   \>141   \>95   0.54    1.01   0.79         
  3                                            BIC/FTC/TAF                               baseline     first              \<50                                                    S119T                                                         none                                                                             --     --      --     --      --     --     --     --
  week 24                                      last[^c^](#tblfn4){ref-type="table-fn"}   499          AF                 AF                                                      AF                                                            AF                                                                               AF     AF      AF     AF      AF     AF          
  4                                            BIC/FTC/TAF                               baseline     first              159                                                     none                                                          V106V/I                                                                          --     --      --     --      --     --     --     --
  week 4                                       cVF                                       206          AF                 V106I                                                   AF                                                            AF                                                                              0.75   1.09    0.98   0.75    0.83   0.80         
  week 8                                       cVF                                       117          AF                 V106I                                                   AF                                                            AF                                                                              0.94   1.22    0.96   0.84    0.94   0.55         
  week 48                                      last                                      \<50         ND                 ND                                                      --                                                            --                                                                               --     --      --     --      --     --          
  5                                            BIC/FTC/TAF                               baseline     first              \<50                                                    S119P                                                         K103N                                                                            --     --      --     --      --     --     --     --
  week 36                                      cVF                                       1500         AF                 AF                                                      AF                                                            AF                                                                               AF     AF      AF     AF      AF     AF          
  week 48                                      last                                      \<50         ND                 ND                                                      --                                                            --                                                                               --     --      --     --      --     --          
  6                                            Boosted PI (DRV + RTV + ABC/3TC)          baseline     first              6980                                                    none                                                          V118I                                                                            AF     AF     0.94   1.02    1.09   0.92   0.97   0.64
  week 4                                       last[^c^](#tblfn4){ref-type="table-fn"}   874          AF                 **L74L/V**, V118I                                       AF                                                            AF                                                                              1.22   1.17    1.35   0.85    0.86   0.80         
  7                                            Boosted PI (DRV/COBI + FTC/TDF)           baseline     first              99900                                                   none                                                          V90I, M184I                                                                     0.89   0.98    2.17   \>141   \>95   0.50   0.64   0.47
  week 8                                       cVF                                       1060         none               V90I, M184I                                             0.84                                                          0.88                                                                            2.31   \>127   \>94   0.50    0.69   0.43         
  week 36                                      last[^c^](#tblfn4){ref-type="table-fn"}   171          ND                 ND                                                      --                                                            --                                                                               --     --      --     --      --     --          
  8                                            Boosted PI (ATV + RTV + FTC/TDF)          baseline     first              \<50                                                    S119S/A/G/T                                                   K103N                                                                            --     --      --     --      --     --     --     --
  week 36                                      cVF                                       1580         none               K103N, **E138E/K**[^e^](#tblfn6){ref-type="table-fn"}   0.84                                                          0.78                                                                            1.01   1.05    1.23   0.85    0.51   0.33         
  week 48                                      cVF                                       982          S119S/A/G/T        K103N, **E138E/K**[^e^](#tblfn6){ref-type="table-fn"}   0.98                                                          1.01                                                                            0.81   1.06    0.98   0.85    0.54   0.41         
  week 48                                      last                                      621          ND                 ND                                                      --                                                            --                                                                               --     --      --     --      --     --          
  9                                            Boosted PI (DRV/COBI + FTC/TDF)           baseline     first              \<50                                                    none                                                          V106V/I                                                                          --     --      --     --      --     --     --     --
  week 8                                       cVF                                       384          AF                 none                                                    AF                                                            AF                                                                              0.79   1.14    1.03   0.86    0.97   0.49         
  week 48                                      last                                      40           ND                 ND                                                      --                                                            --                                                                               --     --      --     --      --     --          
  10                                           Boosted PI (DRV/COBI + FTC/TDF)           baseline     first              \<50                                                    M50M/I                                                        none                                                                             --     --      --     --      --     --     --     --
  week 12                                      cVF                                       357          AF                 none                                                    AF                                                            AF                                                                              1.00   1.30    1.26   0.82    0.72   0.56         
  week 48                                      last                                      47           ND                 ND                                                      --                                                            --                                                                               --     --      --     --      --     --          
  11                                           DTG/ABC/3TC                               baseline     first              \<50                                                    AF                                                            AF                                                                               AF     AF      AF     AF      AF     AF     AF     AF
  week 8                                       last[^c^](#tblfn4){ref-type="table-fn"}   12600        none               none                                                    0.80                                                          0.97                                                                            0.88   1.09    1.09   0.81    0.77   0.74         
  12                                           DTG/ABC/3TC                               baseline     first              \<50                                                    M50I S119R E157Q                                              none                                                                             --     --      --     --      --     --     --     --
  week 12                                      cVF                                       1200         M50I S119R E157Q   none                                                    0.54                                                          0.64                                                                            0.68   0.84    0.96   0.62    0.73   0.40         
  week 48                                      last                                      \<50         ND                 ND                                                      --                                                            --                                                                               --     --      --     --      --     --          

AF, assay failure; ATV, atazanavir; cVF, confirmed virological failure; COBI, cobicistat; ND, not determined; RTV, ritonavir; TFV, tenofovir; --, phenotypic testing not performed.

Resistance substitutions that emerged on study drugs are shown in bold.

Phenotypic fold change represents the half-maximal inhibitory concentration compared with that of the intra-assay WT control. Fold change values greater than or equal to the assay cut-off indicate resistance. Phenotypic cut-offs are 2.5 for bictegravir, 4.0 for dolutegravir, 4.5 for abacavir, 3.5 for lamivudine, 3.5 for emtricitabine, 1.4 for tenofovir (parent compound of tenofovir alafenamide), 5.2 for boosted atazanavir and 10 for boosted darunavir.

Early study drug discontinuation due to participant decision (1, 2, 7 and 11), adverse event (3) or non-compliance (6).

Bictegravir plasma concentrations were undetectable at this study visit and BIC/FTC/TAF adherence was 76% by pill count up to week 12.

The NNRTI resistance substitution E138K emerged at week 36, but was not associated with resistance to the current regimen.

The authors apologize for this error.
